MCRB Earnings
Latest Revenue736.0K
Latest Net Income4.6M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.47 | 736.0K | 4.6M | — | +120.7% |
| Q1 2026 | -$2.08 | 358.0K | -19913000 | — | -155.3% |
| Q4 2025 | -$1.66 | 438.0K | -15335000 | — | +9.3% |
| Q3 2025 | $0.94 | 351.0K | 8.2M | — | -91.9% |
| Q2 2025 | -$2.27 | 0 | -19855000 | — | +47.7% |
| Q1 2025 | $3.76 | 0 | 32.7M | — | +168.5% |
| Q4 2024 | -$1.83 | 0 | -15637000 | — | +71.1% |
| Q3 2024 | $11.63 | 0 | 88.8M | — | +257.2% |
| Q2 2024 | -$4.34 | 0 | -32870000 | — | — |
| Q1 2024 | -$5.49 | 0 | -40133000 | — | — |
| Q4 2023 | -$6.34 | 0 | -41248000 | — | — |
| Q3 2023 | -$7.40 | 0 | -47854000 | — | — |
Seres Therapeutics (MCRB) — Earnings